Chinese scientist’s use of gene-editing tool CRISPR on babies raises serious ethical concerns within the scientific community.
23andMe as well as other spit-in-a-tube genetics companies have been profiting off of selling consumers’ genetic data to drugmakers, but...
The genetic testing company 23andMe has sold its customers' data to GlaxoSmithKline for $500 million. Is this ethically justified? Darshan...